NCT01626066View on ClinicalTrials.gov

Cathepsin Activatable Fluorescent Probe

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2015

Conditions
SarcomaSoft Tissue SarcomaBreast Cancer
Interventions
DRUG

LUM015

LUM015 assigned dose given once by IV push

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

American Society of Clinical Oncology

OTHER

lead

David Kirsch

OTHER

NCT01626066 - Cathepsin Activatable Fluorescent Probe | Biotech Hunter | Biotech Hunter